Screener
Collegium Pharmaceutical, Inc. COLL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s enterprise value?
- Collegium Pharmaceutical, Inc. (COLL) reported enterprise value of $1.03B in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s enterprise value changed year-over-year?
- Collegium Pharmaceutical, Inc.'s enterprise value increased by 23.1% year-over-year, from $835.74M to $1.03B.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s enterprise value has grown at a 18.2% compound annual growth rate (CAGR), from $527.79M to $1.22B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Collegium Pharmaceutical, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude